BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38059899)

  • 1. Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
    Lambertini M; Blondeaux E; Agostinetto E; Hamy AS; Kim HJ; Di Meglio A; Bernstein Molho R; Hilbers F; Pogoda K; Carrasco E; Punie K; Bajpai J; Ignatiadis M; Moore HCF; Phillips KA; Toss A; Rousset-Jablonski C; Peccatori FA; Renaud T; Ferrari A; Paluch-Shimon S; Fruscio R; Cui W; Wong SM; Vernieri C; Ruddy KJ; Dieci MV; Matikas A; Rozenblit M; Villarreal-Garza C; De Marchis L; Del Mastro L; Puglisi F; Del Pilar Estevez-Diz M; Rodriguez-Wallberg KA; Mrinakova B; Meister S; Livraghi L; Clatot F; Yerushalmi R; De Angelis C; Sánchez-Bayona R; Meattini I; Cichowska-Cwalinska N; Berlière M; Salama M; De Giorgi U; Sonnenblick A; Chiodi C; Lee YJ; Maria C; Azim HA; Boni L; Partridge AH;
    JAMA; 2024 Jan; 331(1):49-59. PubMed ID: 38059899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
    Copson ER; Maishman TC; Tapper WJ; Cutress RI; Greville-Heygate S; Altman DG; Eccles B; Gerty S; Durcan LT; Jones L; Evans DG; Thompson AM; Pharoah P; Easton DF; Dunning AM; Hanby A; Lakhani S; Eeles R; Gilbert FJ; Hamed H; Hodgson S; Simmonds P; Stanton L; Eccles DM
    Lancet Oncol; 2018 Feb; 19(2):169-180. PubMed ID: 29337092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy After Breast Cancer in Patients With Germline
    Lambertini M; Ameye L; Hamy AS; Zingarello A; Poorvu PD; Carrasco E; Grinshpun A; Han S; Rousset-Jablonski C; Ferrari A; Paluch-Shimon S; Cortesi L; Senechal C; Miolo G; Pogoda K; Pérez-Fidalgo JA; De Marchis L; Ponzone R; Livraghi L; Estevez-Diz MDP; Villarreal-Garza C; Dieci MV; Clatot F; Berlière M; Graffeo R; Teixeira L; Córdoba O; Sonnenblick A; Luna Pais H; Ignatiadis M; Paesmans M; Partridge AH; Caron O; Saule C; Del Mastro L; Peccatori FA; Azim HA
    J Clin Oncol; 2020 Sep; 38(26):3012-3023. PubMed ID: 32673153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
    Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
    Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
    BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
    Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
    JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
    Andrieu N; Goldgar DE; Easton DF; Rookus M; Brohet R; Antoniou AC; Peock S; Evans G; Eccles D; Douglas F; Noguès C; Gauthier-Villars M; Chompret A; Van Leeuwen FE; Kluijt I; Benitez J; Arver B; Olah E; Chang-Claude J; ; ; ;
    J Natl Cancer Inst; 2006 Apr; 98(8):535-44. PubMed ID: 16622123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
    Kauff ND; Domchek SM; Friebel TM; Robson ME; Lee J; Garber JE; Isaacs C; Evans DG; Lynch H; Eeles RA; Neuhausen SL; Daly MB; Matloff E; Blum JL; Sabbatini P; Barakat RR; Hudis C; Norton L; Offit K; Rebbeck TR
    J Clin Oncol; 2008 Mar; 26(8):1331-7. PubMed ID: 18268356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
    Shah PD; Patil S; Dickler MN; Offit K; Hudis CA; Robson ME
    Cancer; 2016 Apr; 122(8):1178-84. PubMed ID: 26859126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of female breast cancer according to BRCA mutation status.
    Cronin-Fenton DP; Kjærsgaard A; Nørgaard M; Pedersen IS; Thomassen M; Kaye JA; Gutierrez L; Telford C; Lewis J; Tyczynski JE; Sørensen HT
    Cancer Epidemiol; 2017 Aug; 49():128-137. PubMed ID: 28601786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer and Pregnancy in Young BRCA Carriers.
    Narod SA
    JAMA; 2024 Apr; 331(14):1233-1234. PubMed ID: 38592393
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation.
    Valentini A; Lubinski J; Byrski T; Ghadirian P; Moller P; Lynch HT; Ainsworth P; Neuhausen SL; Weitzel J; Singer CF; Olopade OI; Saal H; Lyonnet DS; Foulkes WD; Kim-Sing C; Manoukian S; Zakalik D; Armel S; Senter L; Eng C; Grunfeld E; Chiarelli AM; Poll A; Sun P; Narod SA;
    Breast Cancer Res Treat; 2013 Nov; 142(1):177-85. PubMed ID: 24136669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
    Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.
    Hahnen E; Lederer B; Hauke J; Loibl S; Kröber S; Schneeweiss A; Denkert C; Fasching PA; Blohmer JU; Jackisch C; Paepke S; Gerber B; Kümmel S; Schem C; Neidhardt G; Huober J; Rhiem K; Costa S; Altmüller J; Hanusch C; Thiele H; Müller V; Nürnberg P; Karn T; Nekljudova V; Untch M; von Minckwitz G; Schmutzler RK
    JAMA Oncol; 2017 Oct; 3(10):1378-1385. PubMed ID: 28715532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
    Garcia-Etienne CA; Barile M; Gentilini OD; Botteri E; Rotmensz N; Sagona A; Farante G; Galimberti V; Luini A; Veronesi P; Bonanni B
    Ann Surg Oncol; 2009 Dec; 16(12):3380-7. PubMed ID: 19649554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ARTs on oncological outcomes in young breast cancer survivors.
    Condorelli M; De Vos M; Lie Fong S; Autin C; Delvigne A; Vanden Meerschaut F; Wyns C; Imbert R; Cheruy C; Bouziotis J; de Azambuja E; Delbaere A; Lambertini M; Demeestere I
    Hum Reprod; 2021 Jan; 36(2):381-389. PubMed ID: 33289029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Olaparib for Patients with
    Tutt ANJ; Garber JE; Kaufman B; Viale G; Fumagalli D; Rastogi P; Gelber RD; de Azambuja E; Fielding A; Balmaña J; Domchek SM; Gelmon KA; Hollingsworth SJ; Korde LA; Linderholm B; Bandos H; Senkus E; Suga JM; Shao Z; Pippas AW; Nowecki Z; Huzarski T; Ganz PA; Lucas PC; Baker N; Loibl S; McConnell R; Piccart M; Schmutzler R; Steger GG; Costantino JP; Arahmani A; Wolmark N; McFadden E; Karantza V; Lakhani SR; Yothers G; Campbell C; Geyer CE;
    N Engl J Med; 2021 Jun; 384(25):2394-2405. PubMed ID: 34081848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.